Genome-wide endogenous DAF-16/FOXO recruitment dynamics during lowered insulin signalling in C. elegans
View/ Open
Date
2015Author
Kumar, N.
Jain, V.
Singh, A.
Jagtap, U.
Verma, S.
Mukhopadhyay, A.
Metadata
Show full item recordAbstract
Lowering insulin-IGF-1-like signalling (IIS) activates FOXO transcription factors (TF) to extend life span across species. To study the dynamics of FOXO chromatin occupancy under this condition in C. elegans, we report the first recruitment profile of endogenous DAF-16 and show that the response is conserved. DAF-16 predominantly acts as a transcriptional activator and binding within the 0.5 kb promoter-proximal region results in maximum induction of downstream targets that code for proteins involved in detoxification and longevity. Interestingly, genes that are activated under low IIS already have higher DAF-16 recruited to their promoters in WT. DAF- 16 binds to variants of the FOXO consensus sequence in the promoter proximal regions of genes that are exclusively targeted during low IIS. We also define a set of 'core' direct targets, after comparing multiple studies, which tend to co-express and contribute robustly towards IIS-associated phenotypes. Additionally, we show that nuclear hormone receptor DAF-12 as well as zinc-finger TF EOR-1 may bind DNA in close proximity to DAF-16 and distinct TF classes that are direct targets of DAF-16 may be instrumental in regulating its indirect targets. Together, our study provides fundamental insights into the transcriptional biology of FOXO/DAF-16 and gene regulation downstream of the IIS pathway.
Journal
Oncotarget
URL
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=6282&path[]=16324Collections
Related items
Showing items related by title, author, creator and subject.
-
Pharmacological and molecular approaches for the treatment of ?-hemoglobin disorders
Lohani, N.; Bhargava, N.; Munshi, A.; Ramalingam, S. (Wiley-Liss Inc., 2018)?-hemoglobin disorders, such as ?-thalassemia and sickle cell anemia are among the most prevalent inherited genetic disorders worldwide. These disorders are caused by mutations in the gene encoding hemoglobin-? (HBB), a ... -
PROTAC�ing oncoproteins: targeted protein degradation for cancer therapy
Kelm, Jeremy M.; Pandey, Deepti S.; Malin, Evan; Kansou, Hussein; Arora, Sahil; Kumar, Raj; Gavande, Navnath S. (BioMed Central Ltd, 2023-03-30)Molecularly targeted cancer therapies substantially improve patient outcomes, although the durability of their effectiveness can be limited. Resistance to these therapies is often related to adaptive changes in the target ... -
Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion
Suman, Prabhat; Mehta, Vikrant; Craig, Andrew W. B.; Chander, Harish (Oxford University Press, 2022-01-28)Invading tumor cells develop membrane protruding structures called invadopodia to invade and metastasize. Previously, we have reported the role of formin-binding protein-17 (FBP17) in extracellular matrix degradation and ...